CWA Asset Management Group LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 11.9% in ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Adding CKD to the label for Jardiance (empagliflozin ... helping it to post a near-50% increase in sales for the drug last year to almost $4.4 billion. Boehringer and Lilly's drug is already ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...

Investing in rapidly expanding biotech stocks can be a worthwhile long-term investment. Just one successful drug or device ...

FDA insistence that companies must undertake long-term cardiovascular outcomes trials is transforming the type 2 diabetes market, and Boehringer Ingelheim and Lilly’s Jardiance pill now looks ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

Although the Dow Jones EuroStoxx 50 was only introduced in February 1998, its prices were calculated retroactively back to the year 1986. (read more) The EuroStoxx 50 consists of the shares of the ...

Invest in the best stocks under $50 with Interactive Brokers for fast trade execution. You don’t need thousands of dollars in the bank to get started investing. Just $50, or less, can help you ...

Commissions do not affect our editors' opinions or evaluations. To find the best life insurance for people over 50, we evaluated companies based on their term and cash value policy features and rates.